亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Osteoporosis treatment: recent developments and ongoing challenges

医学 特立帕肽 骨质疏松症 德诺苏马布 重症监护医学 双膦酸盐 生物信息学 内科学 骨矿物 生物
作者
Sundeep Khosla,Lorenz C. Hofbauer
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier]
卷期号:5 (11): 898-907 被引量:691
标识
DOI:10.1016/s2213-8587(17)30188-2
摘要

Osteoporosis is an enormous and growing public health problem. Once considered an inevitable consequence of ageing, it is now eminently preventable and treatable. Ironically, despite tremendous therapeutic advances, there is an increasing treatment gap for patients at high fracture risk. In this Series paper, we trace the evolution of drug therapy for osteoporosis, which began in the 1940s with the demonstration by Fuller Albright that treatment with oestrogen could reverse the negative calcium balance that developed in women after menopause or oophorectomy. We note a watershed in osteoporosis drug discovery around the year 2000, when the approach to developing novel therapeutics shifted from one driven by discoveries in animal studies and clinical observations (eg, oestrogen, calcitonin, and teriparatide) or opportunistic repurposing of existing compounds (eg, bisphosphonates) to one driven by advances in fundamental bone biology (eg, denosumab) coupled with clues from patients with rare bone diseases (eg, romosozumab, odanacatib). Despite these remarkable advances, concerns about rare side-effects of anti-resorptive drugs, particularly bisphosphonates, and the absence of clear evidence in support of their long-term efficacy is leading many patients who could benefit from drug therapy to not take these drugs. As such, there remains an important clinical need to develop ways to enhance patient acceptance and compliance with these effective drugs, and to continue to develop new drugs that do not cause these side-effects and have prolonged anabolic effects on bone. Such changes could lead to a true reversal of this potentially devastating disease of ageing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
spark810应助科研通管家采纳,获得10
35秒前
35秒前
dzhe完成签到,获得积分10
2分钟前
2分钟前
无产阶级科学者完成签到,获得积分10
3分钟前
Huang完成签到 ,获得积分0
3分钟前
Akim应助lhr采纳,获得10
3分钟前
4分钟前
lhr发布了新的文献求助10
4分钟前
CodeCraft应助lhr采纳,获得10
6分钟前
yelide应助科研通管家采纳,获得10
6分钟前
麦子哥应助黄同学采纳,获得10
6分钟前
7分钟前
7分钟前
李月完成签到 ,获得积分10
7分钟前
7分钟前
奉天BB机发布了新的文献求助10
7分钟前
lhr发布了新的文献求助10
7分钟前
大模型应助奉天BB机采纳,获得10
7分钟前
老迟到的元霜完成签到,获得积分10
8分钟前
8分钟前
chiazy完成签到 ,获得积分10
8分钟前
奉天BB机发布了新的文献求助10
8分钟前
慕青应助奉天BB机采纳,获得10
8分钟前
8分钟前
8分钟前
敏感初露发布了新的文献求助10
8分钟前
8分钟前
9分钟前
科研通AI2S应助敏感初露采纳,获得10
9分钟前
9分钟前
yw发布了新的文献求助10
9分钟前
10分钟前
12分钟前
kkpinkman发布了新的文献求助20
12分钟前
kkpinkman完成签到,获得积分20
13分钟前
传奇3应助kkpinkman采纳,获得10
14分钟前
圆圆完成签到 ,获得积分20
15分钟前
15分钟前
橘子味汽水完成签到,获得积分10
15分钟前
高分求助中
Exploring Mitochondrial Autophagy Dysregulation in Osteosarcoma: Its Implications for Prognosis and Targeted Therapy 4000
Impact of Mitophagy-Related Genes on the Diagnosis and Development of Esophageal Squamous Cell Carcinoma via Single-Cell RNA-seq Analysis and Machine Learning Algorithms 2000
Migration and Wellbeing: Towards a More Inclusive World 1200
How to Create Beauty: De Lairesse on the Theory and Practice of Making Art 1000
Evolution 1000
Gerard de Lairesse : an artist between stage and studio 670
On the Refined Urban Stormwater Modeling 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2971017
求助须知:如何正确求助?哪些是违规求助? 2633362
关于积分的说明 7092624
捐赠科研通 2266076
什么是DOI,文献DOI怎么找? 1201603
版权声明 591521
科研通“疑难数据库(出版商)”最低求助积分说明 587625